Skip to main content

Peer Review reports

From: Treatment decisions and the use of MEK inhibitors for children with neurofibromatosis type 1-related plexiform neurofibromas

Original Submission
7 Feb 2023 Submitted Original manuscript
27 Feb 2023 Reviewed Reviewer Report - Thorsten Rosenbaum
18 Mar 2023 Reviewed Reviewer Report - Angela Mastronuzzi
11 May 2023 Author responded Author comments - Amy Armstrong
15 May 2023 Reviewed Reviewer Report - Thorsten Rosenbaum
20 May 2023 Reviewed Reviewer Report - Angela Mastronuzzi
Resubmission - Version 2
11 May 2023 Submitted Manuscript version 2
Publishing
22 May 2023 Editorially accepted
16 Jun 2023 Article published 10.1186/s12885-023-10996-y

You can find further information about peer review here.

Back to article page